See more : Israel Corporation Ltd (ILCO.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Jushi Holdings Inc. (JUSHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jushi Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- AI/ML Innovations Inc. (AIML.CN) Income Statement Analysis – Financial Results
- IFB Industries Limited (IFBIND.NS) Income Statement Analysis – Financial Results
- Post Holdings Partnering Corporation (PSPC-WT) Income Statement Analysis – Financial Results
- Yomeishu Seizo Co., Ltd. (2540.T) Income Statement Analysis – Financial Results
- Vizionfocus Inc. (4771.TW) Income Statement Analysis – Financial Results
Jushi Holdings Inc. (JUSHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jushico.com
About Jushi Holdings Inc.
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabidiol supplements, tinctures, capsules, softgels, and topicals under The Bank, The Lab, Nira+ Medicinals, Seche, Tasteology, and Nira brands. As of June 6, 2022, it operated 33 BEYOND/HELLO retail locations. The company was incorporated in 2007 and is headquartered in Boca Raton, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 269.45M | 284.28M | 209.29M | 80.77M | 10.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 153.22M | 188.81M | 121.92M | 37.70M | 5.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 116.23M | 95.48M | 87.37M | 43.07M | 4.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 43.14% | 33.59% | 41.75% | 53.32% | 47.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 315.63K | 914.63K | 1.23M | 1.42M | 3.04M | 1.75M | 26.77K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.96K | 0.00 | 113.04K | 194.52K | 165.85K | 228.23K | 0.00 | 0.00 |
SG&A | 110.47M | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 336.59K | 914.63K | 1.23M | 1.42M | 3.21M | 1.98M | 26.77K | 37.12K |
Other Expenses | 8.57M | -482.00K | 6.84M | 5.07M | 2.16M | 0.00 | 0.00 | 1.17K | 37.70K | 279.10K | 134.92K | 155.94K | 30.32K | 0.00 | 0.00 |
Operating Expenses | 119.05M | 156.17M | 108.53M | 51.49M | 35.50M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
Cost & Expenses | 272.26M | 344.97M | 230.45M | 89.19M | 40.90M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
Interest Income | 0.00 | 142.00K | 243.00K | 231.00K | 378.49K | 1.07M | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 0.00 | 156.00 | 0.00 |
Interest Expense | -36.97M | 45.73M | 31.20M | 19.13M | 3.25M | 0.00 | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 2.66K | 156.00 | -37.12K |
Depreciation & Amortization | 27.08M | 26.49M | 8.41M | 4.43M | 2.23M | -15.37K | 7.72K | -3.40M | 15.12K | 17.26K | 14.79K | 18.46K | 11.69K | -156.00 | 0.00 |
EBITDA | 30.91M | -121.65M | -10.89M | -7.10M | -38.64M | -142.51K | -72.64K | -3.74M | -944.29K | -1.50M | -1.50M | -3.31M | -2.00M | -26.77K | -37.12K |
EBITDA Ratio | 11.47% | -12.15% | -5.20% | -8.79% | -239.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -2.82M | -60.69M | -20.36M | -8.42M | -30.67M | -127.15K | -80.36K | -337.76K | -952.32K | -1.50M | -1.58M | -3.40M | -2.01M | -26.62K | -37.12K |
Operating Income Ratio | -1.05% | -21.35% | -9.73% | -10.43% | -299.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -31.09M | -113.34M | 88.22M | -185.34M | 7.89M | 15.37K | 7.72K | -3.40M | 19.60K | 28.83K | 48.10K | 92.24K | 0.00 | 0.00 | 0.00 |
Income Before Tax | -33.91M | -193.88M | 52.45M | -201.47M | -26.26M | -111.78K | -72.64K | -3.74M | -932.72K | -1.47M | -1.53M | -3.31M | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -12.58% | -68.20% | 25.06% | -249.42% | -256.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 32.39M | 8.45M | 31.09M | 10.40M | 4.51M | -15.37K | -7.72K | 3.40M | -39.20K | -75.87K | -33.58K | -115.26K | -5.31K | -312.00 | 37.12K |
Net Income | -66.30M | -202.32M | 20.25M | -211.87M | -30.77M | -111.78K | -64.92K | -7.14M | -932.72K | -1.47M | -1.53M | -3.31M | -2.01M | -26.62K | -37.12K |
Net Income Ratio | -24.60% | -71.17% | 9.68% | -262.30% | -300.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.34 | -1.06 | 0.12 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
EPS Diluted | -0.34 | -0.99 | -0.41 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
Weighted Avg Shares Out | 194.77M | 190.02M | 170.29M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
Weighted Avg Shares Out (Dil) | 194.77M | 204.24M | 201.61M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
These Marijuana Stocks Could Hold Strong Long-Term Value
Jushi Holdings Inc. (JUSHF) Q4 2023 Earnings Call Transcript
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Seed to Profit: The Top Cannabis Penny Stocks to Watch
Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
2 Marijuana Stocks To Watch To Start The New Week
Top 3 Marijuana Stocks For Investors To Keep An Eye On
Jushi Announces Support of Adult-Use Cannabis in Pennsylvania Governor's Annual Budget Proposal and Address
Cannabis stocks see fifth straight week of gains ahead of earnings
5 Cannabis Stocks And How Retail Investors Should Navigate The Industry
Source: https://incomestatements.info
Category: Stock Reports